Back to NewsPublished: 5 Jan 2026Download AppJoin TelegramSupriya Lifesciences Targets Rs1,000 Cr Revenue by FY27 – Impact for Investors#Supriya Lifesciences#Revenue Growth#Capacity Expansion#PharmaDownload AppJoin CommunityShare Article